Proteomic Profiling of Antimalarial Plasmodione Using 3-Benz(o)ylmenadione Affinity-Based Probes

Ilaria Iacobucci1,2,3,4, Vittoria Monaco1,2,3,4, Agnès Hovasse2,3

  • 1Laboratoire d'Innovation Moléculaire et Applications (LIMA), Team Bio(IN)organic & Medicinal Chemistry, UMR7042 CNRS-Université de Strasbourg-Université Haute-Alsace, European School of Chemistry, Polymers and Materials (ECPM), 25, rue Becquerel, 25, rue Becquerel, F-67087, Strasbourg, France.

Summary

This study used affinity-based protein profiling to identify how the anti-malarial drug plasmodione works. Researchers found potential drug targets in yeast and Plasmodium parasites, aiding new drug development against malaria.